Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines.

Hana Mahmoud QasimAlaa RahhalAhmed HusainAbdelkarim AlammoraKhaled Alsa'edAhmed Abdelghafar Masaad AlsayedBaha FaiyoumiLeen Maen AbuAfifehMohammad Abu-TinehAwni AlshurafaMohamad A Yassin

Published in: Journal of blood medicine (2023)

mRNA COVID-19 vaccines increase the risk of ITP relapse and can lead to a prolonged reduction in platelet count in a proportion of ITP patients, with no statistically significant difference between Comirnaty and Spikevax vaccines.

Keyphrases

coronavirus disease
sars cov
free survival
binding protein
respiratory syndrome coronavirus
peripheral blood